A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04196283 · COMPLETED
Trial details
- NCT number
- NCT04196283
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2022-10-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.